Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 300

1.

ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.

Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD, Gordon AB, Wald MM, Gupta S, Hoffman SW, Stein DG.

Ann Emerg Med. 2007 Apr;49(4):391-402, 402.e1-2. Epub 2006 Sep 29.

PMID:
17011666
[PubMed - indexed for MEDLINE]
2.

Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.

Marmarou A, Nichols J, Burgess J, Newell D, Troha J, Burnham D, Pitts L.

J Neurotrauma. 1999 Jun;16(6):431-44.

PMID:
10391361
[PubMed - indexed for MEDLINE]
3.

Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial.

Xiao G, Wei J, Yan W, Wang W, Lu Z.

Crit Care. 2008;12(2):R61. doi: 10.1186/cc6887. Epub 2008 Apr 30.

PMID:
18447940
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.

Natale JE, Guerguerian AM, Joseph JG, McCarter R, Shao C, Slomine B, Christensen J, Johnston MV, Shaffner DH.

Pediatr Crit Care Med. 2007 Jan;8(1):1-9.

PMID:
17251875
[PubMed - indexed for MEDLINE]
5.

Neuroprotective effect of gacyclidine. A multicenter double-blind pilot trial in patients with acute traumatic brain injury.

Lepeintre JF, D'Arbigny P, Mathé JF, Vigué B, Loubert G, Delcour J, Kempf C, Tadié M.

Neurochirurgie. 2004 Jun;50(2-3 Pt 1):83-95.

PMID:
15213636
[PubMed - indexed for MEDLINE]
6.

Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial.

Knoller N, Levi L, Shoshan I, Reichenthal E, Razon N, Rappaport ZH, Biegon A.

Crit Care Med. 2002 Mar;30(3):548-54.

PMID:
11990913
[PubMed - indexed for MEDLINE]
7.

[A controlled, double-blind, randomized pilot clinical trial of nicardipine as compared with a placebo in patients with moderate or severe head injury].

Sahuquillo J, Robles A, Poca A, Ballabriga A, Mercadal J, Secades JJ.

Rev Neurol. 2000 Mar 1-15;30(5):401-8. Spanish.

PMID:
10775962
[PubMed - indexed for MEDLINE]
8.

Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial.

Meythaler JM, Brunner RC, Johnson A, Novack TA.

J Head Trauma Rehabil. 2002 Aug;17(4):300-13.

PMID:
12105999
[PubMed - indexed for MEDLINE]
9.

Progesterone in traumatic brain injury: time to move on to phase III trials.

Vandromme M, Melton SM, Kerby JD.

Crit Care. 2008;12(3):153. doi: 10.1186/cc6899. Epub 2008 May 29.

PMID:
18522765
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: results of a multicenter phase II clinical trial. rBPI21 Acute Hemorrhagic Trauma Study Group.

Demetriades D, Smith JS, Jacobson LE, Moncure M, Minei J, Nelson BJ, Scannon PJ.

J Trauma. 1999 Apr;46(4):667-76; discussion 676-7.

PMID:
10217232
[PubMed - indexed for MEDLINE]
11.

A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury.

Merchant RE, Bullock MR, Carmack CA, Shah AK, Wilner KD, Ko G, Williams SA.

Ann N Y Acad Sci. 1999;890:42-50.

PMID:
10668412
[PubMed - indexed for MEDLINE]
12.

Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.

Plenger PM, Dixon CE, Castillo RM, Frankowski RF, Yablon SA, Levin HS.

Arch Phys Med Rehabil. 1996 Jun;77(6):536-40.

PMID:
8831468
[PubMed - indexed for MEDLINE]
13.

Progesterone for acute traumatic brain injury.

Ma J, Huang S, Qin S, You C.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008409. doi: 10.1002/14651858.CD008409.pub3. Review.

PMID:
23076947
[PubMed - indexed for MEDLINE]
14.

[Randomized double-blind clinical trial of moderate dosage naloxone in acute moderate and severe traumatic brain injury].

Chen B, Liu YS.

Hunan Yi Ke Da Xue Xue Bao. 2002 Feb 28;27(1):58-60. Chinese.

PMID:
12575238
[PubMed - indexed for MEDLINE]
15.

Progesterone for acute traumatic brain injury.

Junpeng M, Huang S, Qin S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008409. doi: 10.1002/14651858.CD008409.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;10:CD008409.

PMID:
21249708
[PubMed - indexed for MEDLINE]
16.

"Ultrahigh" dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group.

Gaab MR, Trost HA, Alcantara A, Karimi-Nejad A, Moskopp D, Schultheiss R, Bock WJ, Piek J, Klinge H, Scheil F, et al.

Zentralbl Neurochir. 1994;55(3):135-43.

PMID:
7810251
[PubMed - indexed for MEDLINE]
17.

Reliability and validity of the Pediatric Intensity Level of Therapy (PILOT) scale: a measure of the use of intracranial pressure-directed therapies.

Shore PM, Hand LL, Roy L, Trivedi P, Kochanek PM, Adelson PD.

Crit Care Med. 2006 Jul;34(7):1981-7.

PMID:
16691131
[PubMed - indexed for MEDLINE]
18.

Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion.

Jeremitsky E, Omert L, Dunham CM, Protetch J, Rodriguez A.

J Trauma. 2003 Feb;54(2):312-9.

PMID:
12579057
[PubMed - indexed for MEDLINE]
19.

A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury.

Marmarou A, Guy M, Murphey L, Roy F, Layani L, Combal JP, Marquer C; American Brain Injury Consortium.

J Neurotrauma. 2005 Dec;22(12):1444-55.

PMID:
16379582
[PubMed - indexed for MEDLINE]
20.

Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial.

Firsching R, Piek J, Skalej M, Rohde V, Schmidt U, Striggow F; KN38-7271 Study Group.

J Neurol Surg A Cent Eur Neurosurg. 2012 Aug;73(4):204-16. Epub 2012 Jun 13.

PMID:
22696266
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk